Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2297364/three-reasons-to-hold-bd-bdx-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2297364
Jul 05, 2024 - BD's (BDX) robust product portfolio raises optimism about the stock.
0
BD's (BDX) New Research Tool to Aid Single-Cell Analysis
https://www.zacks.com/stock/news/2294561/bd-s-bdx-new-research-tool-to-aid-single-cell-analysis?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2294561
Jun 27, 2024 - BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
0
Earnings Season Update and Analyst Reports for Broadcom, JNJ & Verizon
https://www.zacks.com/commentary/2286071/earnings-season-update-and-analyst-reports-for-broadcom-jnj-verizon?cid=CS-ZC-FT-research_daily-2286071
Jun 10, 2024 - Today's Research Daily features an earnings season update and new research reports on Broadcom (AVGO), Johnson & Johnson (JNJ) and Verizon (VZ), as well as two micro-cap stocks Taylor Devices, Inc. (TAYD) and Frequency Electronics, Inc. (FEIM).
0
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
https://www.zacks.com/stock/news/2284226/bd-bdx-inks-buyout-deal-to-expand-smart-connected-care-suite?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284226
Jun 05, 2024 - BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
0
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2282887/three-reasons-to-retain-bd-bdx-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2282887
Jun 03, 2024 - BD's (BDX) robust product portfolio raises optimism about the stock.
0
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
https://www.zacks.com/stock/news/2266269/what-s-in-store-for-these-5-medical-device-stocks-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2266269
May 01, 2024 - Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.
0
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
https://www.zacks.com/stock/news/2265409/here-s-why-you-should-hold-lantheus-lnth-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2265409
Apr 30, 2024 - Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
0
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
https://www.zacks.com/stock/news/2262625/revvity-s-rvty-new-launch-to-boost-tuberculosis-testing?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2262625
Apr 25, 2024 - Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
0
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
https://www.zacks.com/stock/news/2261445/penumbra-s-pen-new-launch-to-enhance-blood-clot-removal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2261445
Apr 24, 2024 - Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
0
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
https://www.zacks.com/stock/news/2260548/reasons-why-you-should-retain-healthequity-hqy-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2260548
Apr 23, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
0